David Henry Mack's Net Worth
$2 Million
Who is David Henry Mack?
David Henry Mack has an estimated net worth of $2 Million. This is based on reported shares across multiple companies, which include PMV Pharmaceuticals, Inc., AERIE PHARMACEUTICALS INC, ADURO BIOTECH, INC., and ACELRX PHARMACEUTICALS INC.
SEC CIK
David Henry Mack's CIK is 0001341642
Past Insider Trading and Trends
2021 was David Henry Mack's most active year for acquiring shares with 9 total transactions. David Henry Mack's most active month to acquire stocks was the month of April. 2021 was David Henry Mack's most active year for disposing of shares, totalling 13 transactions. David Henry Mack's most active month to dispose stocks was the month of April. 2023 saw David Henry Mack paying a total of $150,470.71 for 613,907 shares, this is the most they've acquired in one year. In 2021 David Henry Mack cashed out on 108,500 shares for a total of $1,499,996.43, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ACELRX PHARMACEUTICALS INC (ACRX) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +66.31% | 2.79M |
$5.00 | $3,400,000.00 | 7.01M |
Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.6588
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +58.83% | 163.89K |
—
|
—
| 442.46K |
Jan 18
| |||
Form 4
| +80.83% | 198.41K |
$0.53 | $105,155.71 | 443.88K |
Aug 7 - Nov 10
| |||
Form 4
| +106.92% | 85.5K |
$0.53 | $45,315.00 | 165.47K |
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
| +70.26% | 33K |
$0.53 | $17,490.00 | 79.97K |
Apr 27
| |||
Form 4
| +7.85% | 20K |
$1.37 | $27,400.00 | 274.88K |
Mar 9 - Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| +3.66% | 9K |
$0.53 | $4,770.00 | 254.88K |
Dec 9 - Dec 15
| |||
Form 4
| +44.11% | 5.5K |
$0.53 | $2,915.00 | 17.97K |
Aug 19
| |||
Form 4
|
—
|
0
|
$18.14 | -$978,920.05 | 12.47K |
Scheduled
|
Jul 20 - Jul 21
| ||
Form 4
|
—
|
0
|
$18.03 | -$7,140.00 | 12.47K |
Scheduled
|
Jun 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
| +404.86% | 10K |
$0.53 | $5,300.00 | 12.47K |
May 20 - May 21
| |||
Form 4
|
—
|
0
|
$18.09 | -$491,676.38 | 2.47K |
Scheduled
|
May 20 - May 21
| ||
Form 4
|
∞
| 2.47K |
$0.53 | $1,309.10 | 2.47K |
Nov 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AERIE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ADURO BIOTECH, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |